Latest Insider Transactions at Replimune Group, Inc. (REPL)
This section provides a real-time view of insider transactions for Replimune Group, Inc. (REPL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Replimune Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Replimune Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2020
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-0.6%
|
$1,290,000
$43.92 P/Share
|
|
Dec 09
2020
|
Philip Astley Sparke Executive Chairman |
SELL
Open market or private sale
|
Direct |
25,000
-0.37%
|
$1,075,000
$43.93 P/Share
|
|
Dec 09
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
41,216
-0.78%
|
$1,813,504
$44.16 P/Share
|
|
Dec 08
2020
|
Joseph P Slattery Director |
SELL
Open market or private sale
|
Direct |
5,200
-43.82%
|
$239,200
$46.0 P/Share
|
|
Dec 08
2020
|
Joseph P Slattery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,200
+30.47%
|
$15,600
$3.3 P/Share
|
|
Dec 08
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
108,256
-2.94%
|
$4,979,776
$46.49 P/Share
|
|
Dec 07
2020
|
Kapil Dhingra Director |
SELL
Open market or private sale
|
Direct |
40,000
-83.31%
|
$1,840,000
$46.12 P/Share
|
|
Dec 07
2020
|
Kapil Dhingra Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+50.0%
|
$40,000
$1.75 P/Share
|
|
Dec 07
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
67,890
-1.31%
|
$3,122,940
$46.12 P/Share
|
|
Nov 16
2020
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.49%
|
$675,000
$45.29 P/Share
|
|
Oct 14
2020
|
Pamela Esposito Chief Business Officer |
SELL
Open market or private sale
|
Direct |
16,000
-6.42%
|
$512,000
$32.6 P/Share
|
|
Oct 14
2020
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+11.06%
|
$16,000
$1.01 P/Share
|
|
Jul 24
2018
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+14.97%
|
$7,500,000
$15.0 P/Share
|
|
Jul 24
2018
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,338,968
+50.0%
|
-
|
|
Jul 24
2018
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
779,655
+50.0%
|
-
|